跳至主要内容
临床试验/NCT05197686
NCT05197686Unknown不适用

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia: Prognosis and Impact on the Respiratory and Cardiovascular Systems.

Pomeranian Medical University Szczecin2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月18日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Lower mortality in HFNC group

研究概览

简要总结

The aim of the study is to compare two methods of oxygen therapy in patients with acute respiratory distress syndrome in the course of SARS-CoV2 pneumonia. The initial method of oxygen supply during coronavirus pneumonia is conventional oxygen therapy using a face mask or nasal cannula. However, there have been reports in the literature that early initiation of high-flow oxygen therapy with a nasal cannula is associated with better prognosis. The study we perform is intended to provide reliable evidence for confirmation this hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

Groups are designed by web randomizer.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The diagnosis of a current SARS-CoV2 infection (confirmed RT-PCR test or antigen test [allowed in Poland, with sensitivity ≥90 and specificity ≥97]);
  • Hospitalization in the Oxygen Sector of the Temporary Hospital in Szczecin;
  • Pneumonia during SARS-CoV2 infection;
  • ARDS (PaO 2 / FiO 2 ratio ≤300);
  • Oxygen flow 8-12 l / min on mask with reservoir and ≤ 60 mmHg paO2 and / or SpO2 < 92%;
  • TNo current indications for treatment in the ICU;
  • Permisson of the patient.

排除标准

  • Probable lack of cooperation with patient;
  • Severe Disease disease, eg generalized neoplastic disease;
  • Concomitant pulmonary diseases (eg, fibrosis lungs);
  • Respiratory acidosis - pH <7.3 with pCO2> 50 mmHg;
  • Disturbances of consciousness - GCS < 12;

结局指标

主要结局

Lower mortality in HFNC group

时间窗: 6 months

Lower percent of intubation in HFNC group

时间窗: 6 months

Shorter time of hospitalization in HFNC group

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Pomeranian Medical University Szczecin
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验